Evidence map›Paper›PMID 40722351›Full record

ArticleBrain sciences2025

Listening to the Mind: Integrating Vocal Biomarkers into Digital Health.

Irene Rodrigo, Jon Andoni Duñabeitia

Abstract read
In one paragraph

Article in Brain sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Irene RodrigoCentro de Investigación Nebrija en Cognición (CINC), Universidad Nebrija, 28015 Madrid, Spain.
Jon Andoni DuñabeitiaCentro de Investigación Nebrija en Cognición (CINC), Universidad Nebrija, 28015 Madrid, Spain.ORCID 0000-0002-3312-8559

Funding

Spanish Ministry of Science and Innovation PID2021-126884NB-I00
6 · The paper itself

Abstract

The human voice is an invaluable tool for communication, carrying information about a speaker's emotional state and cognitive health. Recent research highlights the potential of acoustic biomarkers to detect early signs of mental health and neurodegenerative conditions. Despite their promise, vocal biomarkers remain underutilized in clinical settings, with limited standardized protocols for assessment. This Perspective article argues for the integration of acoustic biomarkers into digital health solutions to improve the detection and monitoring of cognitive impairment and emotional disturbances. Advances in speech analysis and machine learning have demonstrated the feasibility of using voice features such as pitch, jitter, shimmer, and speech rate to assess these conditions. Moreover, we propose that singing, particularly simple melodic structures, could be an effective and accessible means of gathering vocal biomarkers, offering additional insights into cognitive and emotional states. Given its potential to engage multiple neural networks, singing could function as an assessment tool and an intervention strategy for individuals with cognitive decline. We highlight the necessity of further research to establish robust, reproducible methodologies for analyzing vocal biomarkers and standardizing voice-based diagnostic approaches. By integrating vocal analysis into routine health assessments, clinicians and researchers could significantly advance early detection and personalized interventions for cognitive and emotional disorders.

Indexed as

digital healthmental healthneurodegenerative diseasessingingvocal biomarkers

Identifiers

PMID40722351
PMCPMC12293195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.